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Human skin equiva lents composed ofkeratinocytes cultured 
on a lattice constituted of human fibroblasts embedded in 
type I co ll agen were grafted onto the nude mouse. It is dem-
onstrated, by indirect immunofluorescence and electron mi-
croscopy, that, after grafting, mouse Langerhans cells mi-
grate into the human epidermis. Human Langerhans cells are 
not present in this system. In split-thickness human skin 
grafts, at long periods (5 and 12 months) after transplanta-
tion, a progressive migration of murine la(+) cells in the 
human epidermis and the presence of human Langerhans 
cell s were shown by indirect immunofluorescence. Creation 
of a wound at the center of the grafted human skin and 
identification of the Langerhans cell origin shows a repopu-
Langerhans cells are resident intraepidermal dendritic cell s that constitutively express abundant major histo-compatibili ty complex (MHC) class II molecules, and . possess a characteristic ultrastructural marker, the Bir-beck granule. It is now well known that, in mice [1,2) as 
well as in humans [3 ,4), epidermal Langerhans cells are derived 
from the bone marrow. More recently, other sources of Langer hans 
cells were proposed, the spleen and/or lymph nodes [5). 
Host murine Langerhans cells do not infiltrate human or guinea 
pig skin xenografted onto congenitally athymic nude mice [6). In 
this system, the donor human Langerhans cells persist for the life of 
the graft despite epidermal turnover and absence of circulating 
human precursors [6,7). A flow-cytometric study, performed with 
normal human epidermal cell suspensions double stained with anti-
CO l monoclonal antibody and a DNA dye, demonstrated that 
CDl{+) Langerhans cell s may be found in different phases of the 
cell cycle [8). After injection of the thymidine analogue bromo-
deoxyuridine into nude mice grafted with human skin, Czernie-
lewski and Demarchez determined the percentage of bromodeox-
yuridine-labeled Langerhans cells [9] . Performing double staining 
on skin sections with an anti-bromodeoxyuridine monoclonal anti-
body and anti-CO l antibody, they showed that the number of la-
beled cel ls increases linearly with time and calculated a Langerhans 
cel l cycle of 16.3 d and 12 h for the S-phase. After topical applica-
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lation with human Langerhans cells provided the injury was 
performed early (2 months) after grafting. Injury at a later 
stage (5 months) resulted in presence of both human and 
murine Langerhans cells. These observations show 1) that, 
after grafting of "reconstructed" human skin or of split-
thickness human skin onto nude mice, mouse Langerhans 
cells migrate into the grafted human epidermis; and 2) thar 
the Langerhans cells repopulating a healing grafted epider-
mis devoid of Langerhans cells derive from the non-injured 
surrounding epidermis. The present work thus shows thar 
besides bone marrow, lymph nodes, or/and spleen, sur-
rounding cutaneous regions can also serve as sources of Lan-
gerhans cells. ] Invest Dermatol1 00:648 - 652, 1993 
tion of 12-0-tetradecanoyl-phorboI13-acetate and after tape strip-
ping, the number of bromodeoxyuridine-labeled Langerhans cells 
was increased. Epidermal Langerhans cell mitoses were observed 
ultrastructurally in human skin transplanted onto nude mice. From 
these data, it was concluded that Langerhans cells are active! 
cycling and may form a self-reproducing population in human epi-
dermis. 
The absence of host murine cells in human skin grafted onto nude 
mice ra ises the question of whether this is due to their inability to 
penetrate and survive in the human epidermal environment or 
whether the presence of pre-existing human Langerhans cells inhib-
its the recruitment of host Langerhans cells. To further clarify this 
problem, three different experimental situations in which the Lan-
gerhans cell population was restored or maintained in human epider-
mis were analyzed. W e first determined whether human skin re-
constructed "ill vitro" and devoid of human Langerhans cells would 
be repopulated with host Langerhans cells after transplantation. 
Second, split-thickness human skin transplants were studied follow-
ing long periods after grafting onto nude mice. And third, the reap-
pearance of Langerhans cells was studied in healing epidermis of 
human skin grafted onto nude mice. 
MATERIALS AND METHODS 
Tissue Culture The reconstruction of an epidermis on fibro-
blast-contracted collagen lattices has been previously described [10). 
Briefly, epidermal cell suspensions were obtained, as previously de-
scribed [11) , after separation of dermis from epidermis by trypsini-
zation of split-thickness adult human skin. Isolated epidermal cells 
were expanded in primary culture by co-culture on mitomy. cin-
blocked 3T3 cells [12) . The lattices were produced by casting a 
mixture containing bovine type I collagen (Bioetica, Lyon, France), 
ttypsinized GMI0 human embryonic skin fibrobl as ts, and the tissue 
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,. re 1. Frozen sections of a human skin equivalent, a t 2 months after grafting onto the nude mouse. Indirect immunofluorescent staining at the center ~te graft (0, b,d) or at the junction between human epidermis and mouse epidermis (e), with KLl antibody (a) , anti-67Kd antibody (b), anti-involucrin 
mtibody (c), or anti-transglutaminase antibody (d). HE, human epidermis; HL, human lattice; ME, mouse epidermis. Bar, 100 )lm. 
lrure medium in 60-mm bacteriologic Petri dishes. After 3 d, ~aged human epidermal cells were seeded on the lattices and 
were first kept for 1 week submerged in the cu lture medium to 
tflow epidermal cells to form a con~ue~lt mo.nolayer and were then 
r2ised on stainless steel grids, at the air-liqUid ll1terface. One week of 
Ii! exposure was sufficient to allow stratification and complete dif-
ferentiation of the cultured epidermal cells [13] . 
Grafting Technique. Split-thickness (0.4 mm) skin biopsies 
[1 ern in diameter) obtall1ed from healthy human subj ects undergo-
ing rnammary reduction were grafted as previously described [14] . 
This transplantation method was modified for reconstructed skin 
115]. Briefly, pathogen-free congenitally athymic "nude" mice, Swiss nu/nu (lffa-Credo, Les Oncins, France), ages 5 to 7 weeks, 
were anesthetized with sodium pentobarbital (Nembutal). A graft 
Table 1. Summary of the Presence (+) or Absence (-) of 
Langerhans Cells in the Human Epidermis of 
"Reconstructed" Skin, Normal Skin, or Healing Skin 
After Transplantation onto the Nude Mouse 
Reronstructed human skin 
I, 2, or 3 months after grafting 
.Iormal human skin 
2 months after grafting 
50r 12 months after grafting 
Wounded normal human skin 
Injured at 2 months after grafting 
Injured at 5 months after grafting 
Mouse 
Langerhans 
Cells 
+ 
+ 
+ 
Human 
Langerhans 
Cells 
+ 
+ 
+ 
+ 
site on the anterolateral back was cleansed with 70% ethanol before 
removing a circular piece of whole-thickness skin (1 cm in diame-
ter). The reconstructed skin samples were cut into 1-cm-diameter 
pieces and fitted into the prepared graft sites. The gnfts were 
protected by a surgical tape reinforced with an extensible band-
age. The extensible bandage was changed twice a week for 6 
weeks. 
Skin-Wounding Procedure The wounding procedure was per-
formed as previously described [14,16]. Two or five months after 
transplantation, excisional wounds were made through the entire 
thickness of the skin, at the center of the graft, by performing a 
2-111m punch biopsy. At various tinle intervals thereafter, ranging 
from 7 d to 6 weeks, the wounded graft sites were harvested and 
processed for immunohistologic or ultrastructural studies. 
Antibodies Fluorescein isothiocyanate - or tetral11ethylrodha-
mine isothiocyanate - labeled swine antirabbit immunoglobulin G 
(IgG) globulins from Dakopatts A/S (Denmark), and fluorescein 
isothiocyanate-labeled goat anti-mouse IgG globulins from Tago 
(Burlingame, CA) were used as secondary antibodies. KL1, a mouse 
monoclonal antibody reacting on normal epidermis with the 56.5-
kDa basic keratin polypeptide (Il11l11unotech, Marseille, France) ~ a 
guinea pig polyclonal antibody to human keratin Kl (generous gIft 
of Dr. A. Reano, Lyon, France), a rabbit polyclonal antibody to 
involucrin (Biomedical Technologies, Inc., Stoughton, MA), and 
BCt, a mouse monoclonal antibody to human keratinocyte trans-
glutaminase (generous gift of Dr. S. Thacher, College statIOn, 
Texas), were used as markers of epithelial differentiation. Hum.an 
Langerhans cells were identified with monoclonal antibodies 
against CDla (Orrho, Raritan, NJ) or human leukocyte antlgens 
(HLA)-DR (Becton Dickinson, Mountain View, CAl. A monoclo-
650 DEMARCHEZ ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY 
Figure 2. Pieces of epidermal sheets obtained from human skin equivalents, at 3 months after grafting onto the nude mouse. Indirect immunofluores-
cent staining with anti-lad antibody at the periphery of the graft (a) or in the center of the graft (b) . Bar, 100 lim . 
nal antibody to lad antigen (Becton Dickinson, Mountain View, 
CA) was also used to reveal mouse Langerhans cells in the epidermal 
sheets. 
Immunofluorescence Staining Grafts with surrounding 
mouse skin were harvested 5 and 12 months after grafting. Recon-
structed skin transplants were studied at various intervals after trans-
plantation, ranging from 1 month to 3 months after grafting, and 
wounded grafts 1,2,3, and 6 weeks after wounding. The samples 
were frozen in liquid nitrogen immediately after excision. After 
embedding into Tissue-Tek II (Miles, N aperville, IL) , cryostat sec-
tions (6 ).tm) were cut at -20°C, air dried, and immunolabeled by 
the indirect method at room temperature with the appropriate anti-
bodies. 
To obtain epidermal sheets, skin biopsies were floated dermal side 
down in a petri dish containing 0.5 M ammoniu m thiocyanate for 
40 min, at 37°C [17] and the epidermis was separated from dermis 
w ith fine forceps. After fixation in acetone at 4 ° C for 15 min, the 
epidermal sheets were rehydrated in phosphate-buffered saline, in-
cubated for 16 h at 4 ° C, with the monoclonal antibody to lad anti-
gen, washed in phosphate-buffered saline, and incubated for 1 h 
with fluorescein isothiocyanate-conjugated goat anti-mouse IgG 
diluted 1/ 100. The epidermal sheets were washed once more in 
phosphate-buffered sa line, mounted in 90% (vol/vol) glycerol in 
phosphate-buffered saline containing 5 mM p-phenylenediamine, 
and examined. 
To test the immunospecificity of the immunolabeling protocols, 
control reactions included either omission of the first antibody or its 
Figure 3. Ultrathin section of a Langerhans cell in the epidermis of a 
human skin equivalent, 3 months after grafting onto the nude mouse. 
A rrolVs, Birbeck granules. Bar, 0.5 jim. 
replacement by an isotype-matched antibody reacting with an unre-
lated antigen. 
Electron Microscopy For electron microscopy, specimens were 
fixed for 2 h at room temperature in Karnovsky's solution (2% wlY 
paraformaldehyde, 2.5% w / v glutaraldehyde in 0.1 M cacodylate 
buffer, pH 7.4), then washed in cacodylate buffer containing 5% 
sucrose, post-fixed in 1 % osmium tetroxyde (w Iv), dehydrated, and 
embedded in Epon 812. Thin sections were cut on a Ultracut Rei-
chert Jung ultramicrotome with a diamond knife, double stained 
with lead citrate and uranyl ace tate, and observed in a JEOL JEP-
1200 EX electron microscope operated at 80 kV. To precisely local-
ize the region observed under the electron microscope, semi-thin 
sections (1 ).tm) were stained with toluidine blue. I 
RESULTS AND DISCUSSION 
It is known that reconstructed skin composed of human keratino· 
cytes cultured on a fibrobl ast-retracted collagen lattice can be suc-
cessfully grafted onto nude mice [18] .* However, it seemed impor-
tant to characterize the quality of the epidermis at different times 
after grafting, before studying th e fate of Langerhans cells. One. 
two, or three months after transplantation, KL1 monoclonal anti-
body (Fig la) and anti- 67-kDa keratin antibody (Fig 1b) labeled all 
of the suprabasa l layers as well as a few cells in the basal layer of tht 
grafted reconstructed epidermis . Involucrin (Fig 1e) and transgluta-
minase (Fig 1d) were detected in the upper spinous layers and in th 
granular layers. Because both anti-involucrin or anti-transgluta- I 
minase antibodies are human specific antibodies, these results con· 
firm the human origin of the grafted epidermis. These observations 
show that, up to three months after grafting, a fully differentiat 
human epidermis is present. In a previous publication [15] , it 
reported that, after grafting of such a skin equivalent onto nudr 
mice, a human dermis contai ning human type I collagen and elastic 
fibers and a dermal-epidermal junction containing human type 1'1 
collagen with a normal ultrastructural organization were observ 
[15] . In this grafted reconstructed human skin, the blood vessel. 
were identified to be partly of mouse origin, with a basement mem-
brane produced by both mouse endothelial cells and human fibro-
blasts. These data indicate that reconstructed skin grafted onto th~ 
nude mouse exhibits characteristics very similar to that of graft 
normal human skin . Because Langerhans cells were not detected in 
reconstructed skin before transplantation, it appeared interesting 
see whether mouse Langerhans cells can mi grate into the grafttt 
reconstructed epidermis. Murine lad(+) cells were detected in thl 
• Demarchez M, Asselineau D, Hartmann DJ: An immunohistologic 
and ultrastructural study of human skin reconstructed in vitro and grafted 
onto the nude mouse (abstr). Skin Pharmacol 1:60, 1988. 
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figure 4. Pieces of epidermal sheet obtained from spliHhlckness human ~ 5 mon ths after grafting onto the nude mouse. Indirect immunofluo-~ nt staining with anti-lad antibody (a), anti-COla antibody (b), or an ~e-matched antibody (Ig2a) (e). Bar, 100 11m. 
afted human epidermis one, two, and three months after grafting 
fng 2). An exact quantification was difficult because their distribu-
don was heterogeneous, with a higher density at the periphery of 
the graft (Fig 2) . Under the electron m~croscope, Langerhans cells 
were observed in the human epidermiS 1, 2, or 3 months after 
Igrafting (Fig 3). Altogether, these observations clearly indicate that 
mouse Langerhans cells migrate into a human "reconstructed" epi-
ldermis grafted onto the nude mouse. 
Based on our previous observations, we hypothesized that in 
,plit-thickness human skin grafted onto nude mice, the human Lan-
guhans cells could be replaced by mouse Langerhans cells, but at a 
!Iow rate. This replacement was not detected at early stages (1 and 2 
OIOnths) (Table I) as previously reported by Krueger et al [6]. At 
longer time periods (5 months and 12 months) after grafting, both 
mouse Langerhans cells labeled with anti-lad antibody and human 
l.angerhans cells stained with anti-COla antibody were observed, 
indirect immunofluorescence, in epidermal sheets obtained from 
ese grafts (Fig 4) . Labelin~ with human sp.ecific .antibodies di-
leaed against HLA-ABC antigens or 1I1volucnn l11dlcated that the 
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Figure 5. Frozen sections of human skin transplanted onto the nude 
mouse, one week (a), 2 weeks (b) , or6 weeks (e) after injury. Immunofluo-
rescent staining with anti-HLA-OR antibody (a and b) or anti-COla 
antibody (e). ET, epidermal tongue; HE, human epidermis. Langerhans 
cells are indicated by arrolvs (a). Bar, 100 11m. 
epidermis of the graft remains composed of human keratinocytes, 
even at 12 months after grafting (data not shown). Exact quantifica-
tion of the number of Langerhans cells from each species was diffi-
cult because of the heterogeneous distribution of these cells in the 
epidermis of the grafts. The number of mouse Langerhans cells was 
lower at 5 months after grafting than at 12 months, whereas the 
human Langerhans cells were numerous at 5 months and rare at 12 
months. Moreover, like in the reconstructed skin, murine Langer-
hans cells were more numerous at the periphery than at the center of 
the graft. These observations suggest that mouse Langerhans cells 
migrate into the grafted human epidermis from the surroundi~g 
mouse skin and that this migration is correlated with a decrease 111 
the human Langerhans cell number. 
To further address whether the skin can serve as a source of 
Langerhans cells for other cutaneous regions, a model of skin 
wound healing was investigated. Two previous publications [14, 1 ~l 
demonstrate that human skin transplanted onto the nude mouse IS 
able to entirely regenerate after injury. When a wound is created at 
the center of the grafted human skin through its entire thickness, 
the following overlapping events occur: production of ~ mouse 
granulation tissue, re-epidermization by human cells on tlus mouse 
tissue, replacement of the mouse granulation tissue by a human 
neodermis and reconstruction of an epidermal basement membrane 
with human characteristics. When the wound was made at early 
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Figure 6. Ultrathin section of)..angerhans cell in a wounded epidermis of 
human skin grafted onto the nude mouse, 3 weeks after injury. Birbeck 
granules, indicated by arrows, are clearly distinguishable in the inset. Bar, 
2 !lm; itlset, 0.44 !lm. 
stages after grafting (2 months), human Langerhans cells labeled 
with the anti- HLA-DR or anti-CDla antibodies were absent in the 
migrating epidermal tongue, at 1 week after injury (Fig Sa), but 
were observed in the wounded epidermis at older stages (Fig Sb,c). 
Langerhans cells with their typical Birbeck granules were detected 
by electron microscopy (Fig 6) No mouse Langerhans cell was re-
vealed despite the fact that the human epidermis was in contact with 
a mouse connective tissue. 
When the skin was injured at S months after grafting, i.e., when 
both mouse Langerhans cells and human Langerhans cells were 
present in the grafted human epidermis, Langerhans cells of both 
origin, human and murine, were detected by indirect immunofluo-
rescence in the wounded epidermis (Fig 7a,b) . These observations 
Figure 7. Pieces of epidermal sheets obtained from split-thickness 
human skin injured at 5 months after grafting onto the nude mouse. 
Immunofluorescent labeling with anti-Ia antibody (a) or anti-CD1a anti-
body (b) of the wounded epidermis at 3 weeks after injury. Bar, 100 pm. 
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identify the non-injured epidermis at the periphery of the wound as 
the source of Langerhans cells for the repopulation of the wounded 
epidermis. 
From the present data summarized in Table I, we concluded that 
1) after grafting of "reconstructed" human skin or of split-thickness 
skin onto nude mice, mouse Langerhans cells are able to penetrate 
into the epidermis of the graft; 2) the Langerhans cells repopulating 
a wounded epidermis are provided by the non-injured surrounding 
epidermis. Despite the undisputed fact that Langerhans cells origi-
nate from the bone marrow, it is probable that when their popula-
tion is established in the epidermis, it is maintained or restored by 
two different mechanisms: self reproducibility [8,9]' or as we have 
shown for the case of injury or grafting, migration from adjacent 
epidermis. 
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